Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRANA: OP-101 in Severe COVID-19
NCT04458298Phase 2Terminated
- Start
- Aug 2020
- Primary completion
- Aug 2022
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of N-acetyl cysteine dendrimer conjugate in coronavirus disease 2019 (COVID-19). Started Aug 2020; status: terminated.
02
Drugs
N-acetyl cysteine dendrimer conjugate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04458298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04458298.